Cited 0 times in
Uveitis Risk After the First Dose of COVID-19 Vaccination Based on Uveitis History: Matched Cohort and Crossover Case Series Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김성수 | - |
dc.contributor.author | 김용준 | - |
dc.contributor.author | 변석호 | - |
dc.contributor.author | 이승규 | - |
dc.date.accessioned | 2024-07-18T05:23:12Z | - |
dc.date.available | 2024-07-18T05:23:12Z | - |
dc.date.issued | 2024-06 | - |
dc.identifier.issn | 0002-9394 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/200080 | - |
dc.description.abstract | Purpose: To investigate the risk of noninfectious uveitis following the first dose of coronavirus disease 2019 (COVID-19) vaccination based on the uveitis history. Design: Retrospective matched cohort and crossover case series study. Methods: A random sample of 7 917 457 individuals who received COVID-19 vaccine between January 2021 and March 2022 in Korea, and had no recorded history of COVID-19 were categorized into the control and uveitis groups based on their uveitis history. After performing 3:1 propensity score matching, we assessed the cumulative incidence and risk of noninfectious uveitis in the 180 days after COVID-19 vaccination. Additionally, we performed a crossover case series analysis to compare the pre- and postvaccination incidence rate ratios (IRRs) of uveitis in individuals with and without a history of uveitis. Results: In the matched cohort analysis, uveitis group had a significantly higher cumulative incidence of uveitis (15.4%) than control group (0.10%). The uveitis group exhibited increased risks of all uveitis types, anterior, and nonanterior uveitis in the first 60 days (hazard ratio [HR]: 169, 158, and 253, respectively) and in days 61 to 180 (HR: 166, 164, and 143, respectively) after vaccination. In the crossover case series analysis, uveitis occurred with relatively equal frequency in 20-day intervals during the 180 days before and after vaccination, regardless of uveitis history. For uveitis group, the adjusted IRRs for early and late postvaccination events were 0.92 (95% CI, 0.88-0.96) and 0.83 (95% CI, 0.80-0.85), respectively. Conclusions: COVID-19 vaccination did not increase the risk of uveitis, regardless of uveitis history. © 2024 Elsevier Inc. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Elsevier Science | - |
dc.relation.isPartOf | AMERICAN JOURNAL OF OPHTHALMOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | COVID-19 Vaccines* / administration & dosage | - |
dc.subject.MESH | COVID-19 Vaccines* / adverse effects | - |
dc.subject.MESH | COVID-19* / epidemiology | - |
dc.subject.MESH | COVID-19* / prevention & control | - |
dc.subject.MESH | Cross-Over Studies* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Incidence | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Republic of Korea / epidemiology | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Risk Factors | - |
dc.subject.MESH | SARS-CoV-2* | - |
dc.subject.MESH | Uveitis* | - |
dc.subject.MESH | Vaccination* / adverse effects | - |
dc.subject.MESH | Young Adult | - |
dc.title | Uveitis Risk After the First Dose of COVID-19 Vaccination Based on Uveitis History: Matched Cohort and Crossover Case Series Study | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Ophthalmology (안과학교실) | - |
dc.contributor.googleauthor | Hae Rang Kim | - |
dc.contributor.googleauthor | Sunyeup Kim | - |
dc.contributor.googleauthor | Myung Soo Chang | - |
dc.contributor.googleauthor | Christopher Seungkyu Lee | - |
dc.contributor.googleauthor | Suk Ho Byeon | - |
dc.contributor.googleauthor | Sung Soo Kim | - |
dc.contributor.googleauthor | Seung Won Lee | - |
dc.contributor.googleauthor | Yong Joon Kim | - |
dc.identifier.doi | 10.1016/j.ajo.2024.01.038 | - |
dc.contributor.localId | A00571 | - |
dc.contributor.localId | A05821 | - |
dc.contributor.localId | A01849 | - |
dc.contributor.localId | A02913 | - |
dc.relation.journalcode | J00097 | - |
dc.identifier.eissn | 1879-1891 | - |
dc.identifier.pmid | 38341167 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0002939424000412 | - |
dc.contributor.alternativeName | Kim, Sung Soo | - |
dc.contributor.affiliatedAuthor | 김성수 | - |
dc.contributor.affiliatedAuthor | 김용준 | - |
dc.contributor.affiliatedAuthor | 변석호 | - |
dc.contributor.affiliatedAuthor | 이승규 | - |
dc.citation.volume | 262 | - |
dc.citation.startPage | 125 | - |
dc.citation.endPage | 133 | - |
dc.identifier.bibliographicCitation | AMERICAN JOURNAL OF OPHTHALMOLOGY, Vol.262 : 125-133, 2024-06 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.